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Abstract
Epidemiological studies indicate that the increased consumption of sugars including sucrose and 
fructose in beverages correlate with the prevalence of obesity, type-2 diabetes, insulin resistance, 
hyperinsulinemia, hypertriglyceridemia, and hypertension in humans. A few reports suggest that 
fructose extends lifespan in Saccharomyces cerevisiae. In Anopheles gambiae, fructose, glucose, 
or glucose plus fructose also extended lifespan. New results presented here suggest that fructose 
extends lifespan in Caenorhabditis elegans (C. elegans) wild type (N2). C. elegans were fed 
standard laboratory food source (E. coli OP50), maintained in liquid culture. Experimental groups 
received additional glucose (111 mM), fructose (55 mM, 111 mM, or 555 mM), sucrose (55 mM, 
111 mM, or 555 mM), glucose (167 mM) plus fructose (167 mM) (G&F), or high fructose corn 
syrup (HFCS, 333 mM). In four replicate experiments, fructose dose-dependently increased mean 
lifespan at 55 mM or 111 m Min N2, but decreased lifespan at 555 mM (P < 0.001). Sucrose did 
not affect the lifespan. Glucose reduced lifespan (P < 0.001). Equal amount of G&F or HFCS 
reduced lifespan (P < 0.0001). Intestinal fat deposition (IFD) was increased at a higher dose of 
fructose (555 mM), glucose (111 mM), and sucrose (55 mM, 111 mM, and 555 mM). Here we 
report a biphasic effect of fructose increasing lifespan at lower doses and shortening lifespan at 
higher doses with an inverse effect on IFD. In view of reports that fructose increases lifespan in 
yeast, mosquitoes and now nematodes, while decreasing fat deposition (in nematodes) at lower 
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concentrations, further research into the relationship of fructose to lifespan and fat accumulation in 
vertebrates and mammals is indicated.
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biphasic effect; Caenorhabditis elegans; fructose; high fructose corn syrup (HFCS); lifespan; 
obesity
INTRODUCTION
In 2012, more than one third of children and adults were estimated to be overweight or 
obese in the United States (US) (Ogden et al., 2014). Obesity associated health issues are 
increasing globally, including cardiovascular disease, hypertension, stroke, type 2 diabetes, 
insulin resistance, impaired glucose tolerance, hyperinsulinemia, hypertriglyceridemia, 
nonalcoholic fatty liver disease, and ovarian or colorectal cancer (Gerstein, 1997, DiMeglio 
and Mattes, 2000, Ludwig, Peterson, & Gortmaker, 2001, Elliott et al., 2002, Raben et al., 
2002, Bray, Nielsen, & Popkin, 2004, Cordain et al., 2005, Johnson et al., 2007, Schenewerk 
et al., 2014, Zhang et al., 2014).
Epidemiological studies correlate these obesity-related diseases with sedentary behavior and 
the consumption of excessive energy-dense diets containing saturated fat, sucrose and high-
fructose corn syrup (HFCS) (Burt and Pai, 2001, Ashrafi et al., 2003, Heber, 2010, Mathias, 
Slining, & Popkin, 2013, Ogden et al., 2014, Zheng et al., 2014, Koutoukidis, Knobf, & 
Lanceley, 2015, Sample, Martin et al., 2015). Since HFCS intake increased 10-fold in the 
United States from 1970 to 1990 and accounts for 40% of the consumption of caloric 
sweeteners, the correlation between increased HFCS consumption and increased obesity has 
been speculated to have a cause and effect relationship (Bray et al., 2004). Consumption of 
sucrose decreased 50% as HFCS consumption increased during this time period (DiMeglio 
and Mattes, 2000, Ludwig et al., 2001, Elliott et al., 2002, Raben et al., 2002, Bray et al., 
2004, Johnson et al., 2007, Schenewerk et al., 2014).
The insulin/IGF-1-signaling pathway regulates the lifespan of many organisms including 
yeast, Caenorhabditis elegans (C. elegans), mice, and humans (Barbieri et al., 2003, Lee, 
Murphy, & Kenyon, 2009, Kenyon, 2010, Zheng and Greenway, 2012). In yeast studies, 
either glucose or fructose at a concentration of 0.5% extends the lifespan of Saccharomyces 
cerevisiae mutants compared with a concentration of 2% due to the effect of caloric 
restriction (Smith et al., 2007). Interestingly, Anopheles gambiae consuming a diet 
supplemented with fructose (584 mM) or an equal amount of fructose plus glucose (292 
mM) supported life compared with the water only control (Kessler, Vlimant, & Guerin, 
2015). Feeding fructose to mice did not change body weight compared to a sugar-free, low-
fat dietary control over a 3-month study period, and there was no change in triglycerides, 
free fatty acids, glucose sensitivity or leptin (Tillman et al., 2014).
C. elegans stores energy along the intestinal tract via intestinal fat deposition (IFD), which 
can be directly quantified photometrically by lipid staining dyes in the intact animal. In the 
C. elegans model, glucose as low as 0.1% (5.5 mM) is sufficient to decrease lifespan by 
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decreasing expression of the DAF-16/FOXO gene, a homologue of the human gene FOXO, 
which regulates lifespan, mediates lipid metabolism, regulates insulin/IGF-1 signaling 
pathways, and controls heat shock transcription factor (HSF-1) activity (Ogg et al., 1997, 
Lin et al., 2001, Lee et al., 2009, Solis and Petrascheck, 2011, Zheng et al., 2014, Gao et al., 
2015a, Gao et al., 2015b, Koutoukidis et al., 2015). C. elegans is a small, multicellular, 
transparent, free-living, soil nematode that has a completely sequenced genome and 
conserves 65% of the genes associated with human disease (Fei et al., 2004, Hostetler et al., 
2008, Koutoukidis et al., 2015).
Although many studies have addressed the effect of sugars on obesity and diabetes, little is 
known about the effect of sugars on lifespan. This study evaluated the effects of fructose, 
glucose, and sucrose sugars on C. elegans lifespan and quantified intestinal fat deposition 




Wild type C. elegans (N2) and the standard lab food source Escherichia coli (E. coli, OP50, 
Uracilauxotroph) were obtained from the Caenorhabditis Genetics Center (University of 
Minnesota, Minneapolis, MN). The C. elegans model does not require Institutional Animal 
Care and Use Committee (IACUC) approval.
Culture of Escherichia coli (E. coli, OP50)
OP50 were cultured by the standard method described elsewhere (Zheng et al., 2010). 
Briefly, an E. coli pellet was inoculated into a Luria-Bertani (LB) broth solution containing 
0.2% streptomycin, incubated at 37°C overnight, and stored at 4°C, before being plated on 
petrifilm (3M™ Petrifilm™ E. coli/Coliform Count Plates 6404, 3M Corp., Minneapolis, 
MN) at 37°C for 24 h. Densities of 5 × 108 to 5 × 1011 colony forming units (cfu/mL) were 
selected and fed to C. elegans ad libitum (Gruber, Ng et al., 2009, Zheng et al., 2010). The 
OP50 stock feeding solution was enriched to 2 × 109 cfu/mL by centrifuging at 2,200 g for 
10 minutes and washing twice with S-complete buffer (Solis and Petrascheck, 2011).
Culture of C. Elegans
Mature gravid wild type C. elegans (N2, Bristol) were treated with NaOH (1M) and sodium 
hypochlorite solution (5.25%) at 5:2 ratio to dissolve the body and release viable eggs. Eggs 
were washed with S-complete solution 3 times and hatched overnight at room temperature. 
The age-synchronized C. elegans were diluted to 100 animals/mL, plated in liquid culture in 
96-well plate (120 µL/well, 10–15 animals) (Solis and Petrascheck, 2011) with OP50 (109 
cfu/mL), and incubated in 20°C (N2) low temperature incubators (Revco Tech., Nashville, 
NC, USA). Thirty microliters of 5-Fluoro-2′-deoxyuridine (FUDR, 0.6 mM) stock solution 
were added to each well at larvae 4 stage.
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Glucose, fructose, and sucrose were purchased from Sigma-Aldrich (St. Louis, MO, USA) 
for use in investigating their effect in C. elegans (Solis and Petrascheck, 2011). Fifty 
microliters of the treatments were prepared and fed to the C. elegans on day 3. Each group 
had 60–90 animals (n = 10–15/well × 6 well). The control animals were fed with E. coli 
OP50 only. Experimental groups were fed with additional glucose (111 mM), fructose (55 
mM, 111 mM, or 555 mM), sucrose (55 mM, 111 mM, or 555 mM), glucose (167 mM) plus 
fructose (167 mM), or high fructose corn syrup with 60% fructose (HFCS, 333 mM). The 
96-well plate was placed on a microtiter plate shaker for 2 min before counting. The 
numbers of live animals were manually recorded every other day under an inverted 
microscope with a 4× objective (Nikon Eclipse Ti, Melville, NY, USA) (Lee et al., 2009, 
Zheng et al., 2014). Animals that did not move were excluded from the survival assay. The 
animals were returned to the 20°C incubators thereafter.
Fluorescence Microscopy
Lipophilic dye, Nile red, was used to stain for intestinal fat deposition (IFD) and fluorescent 
intensity was evaluated (Zheng et al., 2010). C. elegans in each group were collected after 3 
days of treatments, washed with S-Basal solution twice, fixed with paraformaldehyde (4%) 
over 2 h at 4°C, and washed with PBS for 5 min three times. Nile red (50 µL) was applied to 
the specimens for 10 min. Ten microliters of Fluoromount-G (Southern Biotechnology 
Associates, Birmingham, AL) was applied to a glass slide followed by 20 µL of the medium 
containing Nile red stained C. elegans. A cover glass was mounted on the glass slide and the 
slides were viewed with an epifluorescence microscope (Nikon Eclipse Ti, Melville, NY) 
equipped with a Texas Red filter. Fluorescent micrographs (n = 10–15) were taken with a 
digital camera (Andor, DU-885k) and analyzed using Nikon-Elements (version 3.22.11). 
Optical densities (arbitrary units, % of control) of Nile red labeled IFD were determined for 
C. elegans (larvae 4).
Statistical Analysis
Analyses were completed using SAS/STAT® software, Version 9.4 of the SAS System for 
Windows (Cary, NC, USA). All results were expressed as means ± standard error of the 
mean (SEM) Survival curves of lifespan were displayed by binomial probabilities as 
surrogates for survival probabilities and the mean survival time (mean lifespan) was 
estimated by Kaplan–Meier analysis. The data for fluorescence intensity was analyzed by 
ANOVA. All P values were calculated based on the comparisons to control group. Statistical 
significance was set at P ≤ 0.05.
RESULTS
Fructose Increased Lifespan and Increased IFD at Higher Doses
Fructose added to the culture significantly and dose-dependently increased mean lifespan up 
to the 111 mM dose but reduced lifespan at higher doses in a biphasic dose–response 
relationship. The average probability of survival across the lifespan was increased at lower 
doses and decreased at a higher dose (Figure 1a). The mean lifespan was increased at lower 
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doses from 17.3 to 21.1 (55 mM, P < 0.0001) or to 25.2 (100 mM, P = 0.0002) days, and 
was decreased at a higher dose from 25.2 to 11.8 (555 mM) days (P < 0.00001, Figure 1b).
The intestinal fat deposition (IFD) of C. elegans measured by Nile red staining was not 
affected by the lower doses of fructose (55 mM or 111 mM, P > 0.05), while it was 
increased 2-fold at the higher dose (555 mM, P < 0.0001, Figure 2a & b).
Sucrose Increased IFD
The average probability of survival across the lifespan was mildly decreased in sucrose 
treated groups (Figure 3). The mean lifespan was slightly increased from 17.3 to 18.2 (555 
mM) days in a dose-dependent trend (P > 0.05, Figure 3 & Figure 1b). Inversely to lifespan 
extension, the IFD was increased by 120% (55 mM), 180% (111 mM), or 90% (555 mM, P 
< 0.0001, Figure 2a & b).
Glucose Reduced Lifespan and Increased IFD
The average probability of survival across the lifespan was decreased in the glucose treated 
group (Figure 1a). The mean lifespan was reduced from 17.3 to 9.2 days (111 mM, P < 0.05, 
Figure 1b). The IFD was increased by 20%, P < 0.05, Figure 2a & b).
Equal Amount of Glucose Plus Fructose (G&F) or High Fructose Corn Syrup (HFCS)-
Reduced Lifespan
The average probability of survival across the lifespan was decreased in the G&F (167 mM 
& 167 mM) or HFCS (333 mM) treated group (Figure 4a). The mean lifespan was reduced 
from 11.8 to 8.2 days for each group (P < 0.05, Figure 4b).
DISCUSSION
In this study, the effects of fructose, sucrose, glucose, glucose plus fructose, or HFCS 
consumption were evaluated in the C. elegans model by measuring alterations in lifespan 
and changes in IFD determined by the fluorescent intensity of Nile red. Lifespan was 
reduced in the glucose treated group as previously reported (Lee et al., 2009, Gao et al., 
2015a, Gao et al., 2015b). Here we report a biphasic effect of fructose increasing lifespan at 
lower doses and shortening lifespan at a higher dose. Sucrose had no significant effect on 
mean lifespan. The mixed glucose & fructose or HFCS treatment reduced lifespan. IFD was 
increased at the higher dose and by glucose and sucrose in this study.
Although sugars are important energy sources for animals and humans, overconsumption 
can threaten health. Consumption of sugar-sweetened beverages can increase 
hyperinsulinemia, heart rate, advanced oxidation of protein products, triacylglycerol in the 
blood, and oxidative stress markers in rodents (Gurecka et al., 2015). Glucose is transported 
into cells by GLUT-4, an insulin-dependent transport system, while fructose is transported 
by GLUT-5 (Basaranoglu, Basaranoglu, & Bugianesi, 2015). A high ratio of fructose to 
glucose can lead to glucose addictive behavior and metabolic disorders in the rat (Levy, 
Marshall et al., 2015). An increased fructose-to-glucose ratio in humans increases fasting 
triglycerides when daily consumption is over 100 g per day, even without a change in body 
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weight (Livesey and Taylor, 2008). Elevation of blood glucose in humans stimulates insulin 
secretion which can lead to weight gain. Rats fed a 32% sugar supplemented diet gain 
significantly more retroperitoneal fat compared to a standard diet (Kanarek and Orthen-
Gambill, 1982).
Similarly, consumption of fructose is linked tomany adverse events and diseases in humans. 
Fructose consumption is a risk factor for metabolic syndrome, an accelerated aging process, 
myocardial infarction, gout, fatty liver disease, impaired adiponectin secretion, 
cardiovascular disease, hypertension, diabetes, and cancer (Perheentupa and Raivio, 1967, 
Ames, Cathcart et al., 1981, Hwang, Ho et al., 1987, Sato et al., 1996, Kang et al., 2005, 
Khosla et al., 2005, Johnson et al., 2007, Sautin, Nakagawa et al., 2007, Gul, Rahman, & 
Hasnain, 2009, Perez-Pozo, Schold et al., 2010, Van Horn and Dietary Guidelines Advisory, 
2010, Suresh and Das, 2012, Kavanagh et al., 2013, Basaranoglu et al., 2015, Levy et al., 
2015). Fructose does not stimulate insulin or leptin secretion in vitro and has a limited 
ability to inhibit food intake, because it is not able to prevent depletion of ATP, which is 
necessary for a homeostatic response in the brain (Perheentupa and Raivio, 1967, Johnson et 
al., 2007). Fructose leads to the generation of lactic acid and hyperuricemia which stimulates 
intestinal epithelial cells and vascular smooth muscle cells to proliferate and release 
chemotactic and inflammatory substances, induce monocyte chemotaxis, and create 
oxidative stress in adipocytes (Kang et al., 2005, Khosla et al., 2005, Sautin, Nakagawa et 
al., 2007).
Citing increased fructose consumption as the cause for the increase in obesity and obesity-
associated diseases that are correlated with caloric sweetener use is controversial (Sun and 
Empie, 2007). Epidemiological studies also find that total energy intake in the U.S. 
population increased by 515 kcal/day (24%) between 1970 and 2008 (USDA-ERS data). Of 
the 515 kcal/day increase in caloric intake, only 58 kcal/day were estimated to come from 
sugar and only half of that, 29 kcal/day, came from fructose, which includes fructose from 
all sources including raw fruits and vegetables (White, 2011, White, 2012, White, 2013). 
Moreover, dietary use of fructose peaked in 1999 followed by a 13-year decline of 39 ± 4 
g/day today (White, 2011, White, 2012, White, 2013). This decrease in fructose 
consumption was coincident with an increasing prevalence of obesity, metabolic syndrome, 
elevated uric acid, and a rising Body Mass Index (BMI) (White, 2011, White, 2012, White, 
2013). Some researchers believe that experimental fructose intake representing 24% of total 
energy is beyond the normal range of human consumption (≤17.9% of energy at 19–22 years 
of age) which has been claimed to show no detrimental effect on human health and 
recommended to diabetic individuals (Anderson, Story et al., 1989, Marriott, Cole,&Lee, 
2009, Sun, Anderson et al., 2011, Kavanagh et al., 2013, White, 2013). One clinical trial 
concluded that fructose and other sugars had no effect on fasting plasma glucose, fasting 
plasma insulin, LDL and total cholesterol, free fatty acids, or leptin (White, 2013, White, 
2013). A recent review of 19 articles from 2006 to 2012 concluded that the “six eligible 
publications” that linked the fructose in HFCS to childhood obesity were based on 
“inconclusive scientific evidence” (Morgan, 2013). As the sweetest of the nutritive 
sweeteners, fructose, a simple monosaccharide found in fruits, vegetables, and honey, is 
bound to glucose forming the disaccharide sucrose. Fructose has a low glycemic index (GI) 
and is the least cariogenic of the nutritive sugars compared with sucrose and glucose (Cury, 
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Rebelo et al., 2000, Bantle, 2006, Cozma et al., 2012). Interestingly, in human studies, lower 
amounts of daily fructose intake (50–100 g) were related to reduced dysglycemia and 
glycated hemoglobin (HbA1c) (Huttunen, 1976, Livesey and Taylor, 2008). Thus, adverse 
effects of fructose may only occur with preexisting dyslipidemia, as substitution of fructose 
in isocaloric diets does not cause adverse effects on lipid metabolism (Chiavaroli et al., 
2015).
Many studies have addressed the adverse effects of sugars on obesity and diabetes. With this 
in mind, we tested three common sugars that are used in foods and beverages. To our 
surprise, provided that we used equal molar amounts of each sugar, we observed 
heterogeneous effects of the sugars on lifespan and IFD in C. elegans. The biphasic dose-
response curve seen with fructose, which increased lifespan at lower doses and reduced at 
higher doses, supported the results of some other studies using low or high doses (Smith et 
al., 2007, Kessler et al., 2015). The reduced lifespan by glucose & fructose or HFCS may be 
related to the dose that could be in the declining lifespan range of fructose treatment alone. 
Our results with fructose differ from the conclusions of epidemiological studies.
Similarly as in humans reporting, where lower amounts of daily fructose intake (50–100 g) 
reduced dysglycemia and HbA1c without having adverse effect on lipid metabolism except 
preexisting dyslipidemia (Livesey and Taylor, 2008), we observed that lower doses of 
fructose extended lifespan. Higher dose of fructose reduced lifespan and increased IFD, 
which is in agreement with results from human studies that have demonstrated elevations of 
triacylglycerol, body weight, and fat mass at higher doses of fructose (Herman, Zakim, & 
Stifel, 1970, Elliott et al., 2002). In rats, sucrose supplemented diets shorten mean lifespan 
and elevate blood pressure. In the fruit fly (Drosophila melanogaster) sucrose reduced 
lifespan and increased levels of body fat (Preuss et al., 1991, Rovenko et al., 2015). Our 
results showed no change in lifespan with sucrose. Glucose increased intestinal fat 
deposition and reduced the lifespan in C. elegans which is consistent with previous studies 
(Zheng et al., 2014, Gao et al., 2015a).
In summary, glucose increased IFD and shortened lifespan, sucrose increased IFD without 
affecting lifespan, and fructose increased lifespan while increasing IFD at higher doses in C. 
elegans. These data, along with results from studies showing increased lifespan with fructose 
in yeast and mosquitoes, suggest the need to assess the dose response effect of fructose on 
lifespan and IFD in higher animal models to further evaluate if lower doses of fructose may 
have implications for humans.
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Glucose, fructose, and sucrose affected lifespan of wild-type C. elegans (N2) and their mean 
survival days. (A) Survival curves of lifespan were displayed by binomial probabilities as 
surrogates for survival probabilities. (B) The mean survival time (mean lifespan) was 
estimated by Kaplan–Meier analysis. Low doses of fructose (55 mM and 111 mM) increased 
mean lifespan (P < 0.05). The P values of lifespan reflect the Kaplan–Meier probabilities (*P 
< 0.05).
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Glucose, fructose, and sucrose affected intestinal fat deposition (IFD, *P < 0.05). High dose 
of fructose (555 mM) increased IFD (P < 0.05). All three doses of sucrose (55 mM, 111 mM 
& 555 mM) increased IFD, and glucose (111 mM) also increased IFD (P < 0.05).
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Sucrose did not significantly alter the mean survival time (mean lifespan) estimated by 
Kaplan-Meier analysis. Survival curves of lifespan were displayed by binomial probabilities 
as surrogates for survival probabilities.
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Glucose plus fructose (G&F) or high fructose corn syrup (HFCS) reduced lifespan. (A) 
Survival curves of lifespan were displayed by binomial probabilities as surrogates for 
survival probabilities. (B) The mean survival time (mean lifespan) was estimated by Kaplan–
Meier analysis. G167 mM & F167 mM and HFCS 333 mM decreased the mean lifespan (P 
< 0.05). The P values of lifespan reflect the Kaplan–Meier probabilities (*P < 0.05).
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